Maxwell RSC 48 DNA Extraction Systems

Closed Pre-Solicitation Posted

Not the latest version. See the latest solicitation from .

Solicitation number
HFP-2026-133524
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Irvine, California, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The U.S. Food and Drug Administration (FDA), Office of Acquisition and Grant Services, is conducting market research to identify qualified sources for Promega Maxwell RSC 48 DNA Extraction Systems to support regulatory molecular detection methods across FDA field laboratories over a five-year contract period. This is a Sources Sought Notice only and does not constitute a solicitation or commitment to award a contract. Potential vendors must demonstrate capability to provide newly manufactured systems with specified components, deliver within 90 days on a firm-fixed-price basis, complete installation and on-site training within 14 days, and provide a minimum one-year warranty with unlimited telephone and email support. The Government is particularly interested in responses from small businesses, small disadvantaged businesses, women-owned small businesses, service-disabled veteran-owned small businesses, HUBZone small businesses, and 8(a) Business Development Program participants. All responses must be submitted electronically in PDF format not exceeding 10 pages by April 22, 2026 at 10:00 AM Eastern Time to Michele Jackson at Michele.Jackson@fda.hhs.gov. Respondents must be registered in the System for Award Management (SAM) to be eligible for any future contract award.

No set-aside designation has been applied to this opportunity, and competition will be limited to the manufacturer and authorized resellers of the Promega Maxwell RSC 48 DNA Extraction System. The base year requirement calls for delivery of seven systems to laboratories located in Irvine, California; Jefferson, Arkansas; Atlanta, Georgia; Alameda, California; Jamaica, New York; Denver, Colorado; and Bothell, Washington, with one to two additional systems anticipated per year during four option years. The anticipated acquisition vehicle is a Blanket Purchase Agreement with firm-fixed pricing structured as a 12-month base period followed by four 12-month option periods, conducted as limited competition under Federal Acquisition Regulation 13.501(a)(1)(ii). Vendors must provide company information including DUNS/UEI numbers, CAGE codes, SAM registration status, business size classification, applicable socioeconomic certifications, GSA Federal Supply Schedule contract status, pricing information or capabilities statements, geographic coverage, and experience with federal government contracts. No budget range or award value is specified in this market research notice, and the Government disclaims any obligation to reimburse response costs or issue a future solicitation.

Notice text

This is a Sources Sought Notice only and shall not be construed as a solicitation or as an obligation on the part of the Government to acquire any products or services. The purpose of this notice is to gain knowledge of potential qualified sources and their size classification relative to NAICS code [Insert Code] in support of market research.

The U.S. Food and Drug Administration (FDA), Office of Acquisition and Grant Services (OAGS), on behalf of the Office of Laboratory Operations and Applied Science (OLOAS), Office of Regulatory Testing and Surveillance (ORTS), is conducting market research to identify potential sources capable of providing Maxwell RSC 48 DNA Extraction Systems over a five-year contract period.

This notice is issued solely for information and planning purposes and does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. This notice does not commit the Government to contract for any supply or service.  

Please review the attached Sources Sought Notice (SSN) and respond using the attached SSN response form on or before April 22, 2026@10:00 am to Michele Jackson at Michele.Jackson@fda.hhs.gov.

Files

File Type Posted
SSN Response Form HFP-2026-133524.docx DOCX document
Sources sought notice HFP-2026-133524.docx DOCX document

Notice history

Notice Type Posted
Maxwell RSC 48 DNA Extraction Systems or Equal – Commercial Blanket Purchase Agreement (BPA) Latest solicitation Solicitation
This notice Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity